EMD Millipore Expands Bioavailability Enhancement Capabilities
EMD Millipore, the life science division of Merck KGaA (Darmstadt, Germany), has announced the opening of a new Research & Development Center for Formulation in Darmstadt, Germany. The center is made up of formulation, analytical, and synthetic laboratories with a customer-training center.
EMD Millipore, the life science division of Merck KGaA (Darmstadt, Germany), has announced the opening of a new Research & Development Center for Formulation in Darmstadt, Germany. The center is made up of formulation, analytical, and synthetic laboratories with a customer-training center.
The center has been established to expand EMD Millipore capabilities for the enhancement of bioavailability to meet the needs of pharmaceutical analysis, according to Burghard Freiberg, senior VP, pharma chemicals solutions.
Freiberg said: "There is a clear market need for a comprehensive set of innovative products and technologies to support bioavailability enhancement. At our new center for formulation, we can help customers overcome formulation-related challenges, such as insufficient API performance due to poor solubility and life cycle management developments, in a more effective and efficient manner."
For more information please visit:
Exploring Nitrogen Exudation in Cotton with HPLC and FT-ICR-MS
December 5th 2024Researchers used high performance liquid chromatography and untargeted metabolomics by Fourier-transform ion cyclotron resonance-mass spectrometry to highlight the critical role of root exudates in drought tolerance.
Inside the Laboratory: Using GC–MS to Analyze Bio-Oil Compositions in the Goldfarb Group
December 5th 2024In this edition of “Inside the Laboratory,” Jillian Goldfarb of Cornell University discusses her laboratory’s work with using gas chromatography–mass spectrometry (GC–MS) to characterize compounds present in biofuels.
